Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Non-Current Deferred Tax Liability (2023 - 2026)

Moolec Science (MLECW) posted Non-Current Deferred Tax Liability of $14.3 million for Q1 2026, little changed sequentially from $14.3 million in Q4 2025.

Moolec Science (MLECW) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends

Moolec Science has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $14.3 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (changed N/A YoY) and the FY2025 annual result came in at $14.4 million, down 58.18% from the prior year.
  • Non-Current Deferred Tax Liability was little changed at $14.3 million in Q1 2026 per MLECW's latest filing, from $14.3 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $34.5 million in Q2 2024 and troughed at $40491.0 in Q3 2024.
  • A 4-year average of $7.5 million and a median of $1.1 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability slumped 95.2% in 2024, then surged 4424.96% in 2025.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $323391.0 in 2023, then retreated by 2.27% to $316039.0 in 2024, then soared by 4424.96% to $14.3 million in 2025, then declined by 0.0% to $14.3 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $14.3 million, $14.3 million, and $14.4 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Moolec Science 8,617.72 -1.19 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 14.30 Mn
Mar 31, 2026 14.30 Mn
Dec 31, 2025 14.30 Mn
Dec 31, 2025 14.30 Mn
Jun 30, 2025 14.43 Mn
Jun 30, 2025 14.43 Mn
Dec 31, 2024 316,039.00
Dec 31, 2024 316,039.00
Sep 30, 2024 40,491.00
Sep 30, 2024 40,491.00
Jun 30, 2024 34.50 Mn
Jun 30, 2024 34.50 Mn
Mar 31, 2024 588,965.00
Mar 31, 2024 588,965.00
Dec 31, 2023 323,391.00
Dec 31, 2023 323,391.00
Sep 30, 2023 843,032.00
Sep 30, 2023 843,032.00
Jun 30, 2023 1.07 Mn
Jun 30, 2023 1.07 Mn